Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
02/23/1999 | US5874534 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
02/23/1999 | US5874533 HIV-2 envelope polypeptides |
02/23/1999 | US5874531 Polypeptides implicated as self epitope in autoimmune disease pemphigus vulgaris and multiple scelerosis |
02/23/1999 | US5874528 Binding peptides which interact with ligand growth factors of the epidermal growth factor receptor and erbB-2 receptor |
02/23/1999 | US5874527 Plasmodium vivax blood stage antigens |
02/23/1999 | US5874526 Toxoplasma gondii antigens |
02/23/1999 | US5874409 Antiphospholipid analog specifically binds antibodies produced by b cells specific for an antiphospholipid epitope and lacks t cell epitopes; where in the analog is a oligopeptide or polypeptide |
02/23/1999 | US5874401 Cedar pollen protein and use thereof in treating, preventing, and diagnosing pollenosis |
02/23/1999 | US5874316 Receptor membranes and ionophore gating |
02/23/1999 | US5874314 Heating a conductive device in a pulsed fashion to thermally ionize molecules; an electrode collects emitted ions, and the resulting current is amplified; heat pulse lasts until no current is detected; low voltage fire detectors |
02/23/1999 | US5874313 Method for quantifying oxidation parameters of low density lipoproteins and use thereof |
02/23/1999 | US5874312 Diagnosis of alzheimer disease stage by mononuclear cell cytokine secretions |
02/23/1999 | US5874311 Simple and efficient quantitative analysis of blood sample by cytolysis of mature erthyrocytes, measuring low angle light scatter signal without staining or fluorescence |
02/23/1999 | US5874310 Method for differentiation of nucleated red blood cells |
02/23/1999 | US5874309 Exposing patterned metals to a corrosion-accelerating environment, calculating the difference in defects between before and after the treatment; stopping and correcting process used to make wafer if corrosion is excessive |
02/23/1999 | US5874305 Androgen-repressed metastatic human prostate cancer cell line |
02/23/1999 | US5874304 Humanized green fluorescent protein genes and methods |
02/23/1999 | US5874303 Sustainable cell line for the production of Marek's disease vaccines |
02/23/1999 | US5874300 Campylobacter jejuni antigens and methods for their production and use |
02/23/1999 | US5874266 Targeted system for removing tumor cells from cell populations |
02/23/1999 | US5874264 Retrovirus |
02/23/1999 | US5874256 Obtaining a sample that contains blood coagulation factor v or factor and assaying for presence of a mutation in amino acid 506 (arginine to glutamine) of human factor v or va caused by decreased deactivation by activated protein c |
02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
02/23/1999 | US5874250 DNA encoding for a protein containing the extracellular domain of lymphocyte activation gene 3 |
02/23/1999 | US5874245 Human G-protein coupled receptor (HIBCD07) |
02/23/1999 | US5874237 Method and apparatus for collecting airborne biological particles |
02/23/1999 | US5874236 DNA encoding human calcium channel α-1A, β1, β-2, and β-4 subunits, and assays using cells that express the subunits |
02/23/1999 | US5874235 Nonsteroidal antiinflammatory agents for increase of ceramids mediated with cyclooxygenase inhibition |
02/23/1999 | US5874233 Methods of diagnosing a clinical subtype of Crohn's disease with features of ulcerative colitis |
02/23/1999 | US5874232 Relating to assay reagents |
02/23/1999 | US5874231 Contacting test agent with complex comprising translation factor sequestered by cell component wherein said complex responds to hormone treatment by releasing translation factor from sequestration; detecting if test agent causes release |
02/23/1999 | US5874227 Binds to corticotropin factor; competitive binding assay for screening ligands |
02/23/1999 | US5874226 In situ immunodetection of antigens |
02/23/1999 | US5874225 Cell line from human rhabdomyosarcoma cell line te671. differentiated cells are characterized by great enlargement |
02/23/1999 | US5874222 M6P/IGF-II receptor tumor suppressor gene |
02/23/1999 | US5874218 Method for detecting a target compound in a substance using a nucleic acid ligand |
02/23/1999 | US5874216 Chromatographic strip positive readout competitive binding assay device |
02/23/1999 | US5874211 Chemokine expressed in eosinophils |
02/23/1999 | US5874209 Regulation of transcription factor, NF-IL6/LAP |
02/23/1999 | US5874085 A drug comprising at least one cytokine stimulants and a b cell activator selected from a cell surface protein and bacterial lipopolysaccharide |
02/23/1999 | US5874047 Etching a body of silicon from an active surface to form a pore network penetrating into body forming a foam structure, lining the pores with nonconductor boundary layer, depositing in the pores reactive materials such as antibody, enzymes |
02/23/1999 | US5873997 Bioreactor and method of measuring contaminants in an aqueous environment |
02/23/1999 | US5873990 Handheld electromonitor device |
02/23/1999 | US5873980 Apparatus and method for recovering solvent |
02/23/1999 | US5873328 Pet leash with length-limited elastic section |
02/23/1999 | CA2176673C Improved sealant for sample holder |
02/23/1999 | CA2136088C Apparatus for drawing fluid sample, components thereof, and a slide assembly for use therewith |
02/23/1999 | CA2050941C Antibody to smooth muscle myosin heavy chains |
02/23/1999 | CA1340405C Method for detecting antibodies to human immunodeficiency virus |
02/23/1999 | CA1340403C Human b lymphotropic virus (hblv) isolation and products |
02/22/1999 | CA2245464A1 Method for examining the foaming behavior of liquids |
02/21/1999 | CA2241428A1 Asp5 |
02/20/1999 | CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor |
02/19/1999 | CA2245310A1 Sca7 gene and methods of use |
02/19/1999 | CA2241433A1 Novel compounds |
02/18/1999 | WO1999008246A1 Carbon monoxide and smoke detection apparatus |
02/18/1999 | WO1999008233A1 A digital imaging system for assays in well plates, gels and blots |
02/18/1999 | WO1999008114A1 Hydrophobic fluorescent polymer membrane for the detection of ammonia |
02/18/1999 | WO1999008113A1 Antigens embedded in thermoplastic |
02/18/1999 | WO1999008112A1 Methods of identifying biological agent compositions |
02/18/1999 | WO1999008111A1 Method for monitoring airborne chemicals |
02/18/1999 | WO1999008110A1 Methods and compositions for overcoming resistance to biologic and chemotherapy |
02/18/1999 | WO1999008109A2 Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma |
02/18/1999 | WO1999008108A1 Determining the transforming capability of agents |
02/18/1999 | WO1999008107A1 Aggregometer with disposable test cell |
02/18/1999 | WO1999008106A1 A method of determining the concentration of an analyte with the use of a bioelement and a device operating in accordance with the method |
02/18/1999 | WO1999008105A1 Techniques and systems for analyte detection |
02/18/1999 | WO1999008104A1 On-line analysis of process gas during the production of ketene |
02/18/1999 | WO1999008102A1 Gas detection device and method |
02/18/1999 | WO1999008095A1 Analytical cartridge |
02/18/1999 | WO1999008091A1 System and method for automatically detecting malignant cells and cells having malignancy-associated changes |
02/18/1999 | WO1999008086A1 Gas analysing apparatus |
02/18/1999 | WO1999007897A1 Magnetic polynucleotide separation and analysis |
02/18/1999 | WO1999007894A1 Direct quantitation of low copy number rna |
02/18/1999 | WO1999007892A1 Array-based detection of genetic alterations associated with disease |
02/18/1999 | WO1999007891A1 90 human secreted proteins |
02/18/1999 | WO1999007882A1 Fluorescent polymeric sensor for the detection of urea |
02/18/1999 | WO1999007881A1 Fluorescent polymeric sensor for the detection of creatinine |
02/18/1999 | WO1999007880A1 IDENTIFICATION OF HUMAN ALLERGENS AND T-LYMPHOCYTE ANTIGENS $i(IN VITRO) |
02/18/1999 | WO1999007879A1 Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures |
02/18/1999 | WO1999007876A2 Method for assaying cellular protein |
02/18/1999 | WO1999007856A1 Novel metalloprotease |
02/18/1999 | WO1999007855A1 Neutral sphingomyelinase |
02/18/1999 | WO1999007850A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
02/18/1999 | WO1999007848A1 Mammalian cytokine receptor-11 |
02/18/1999 | WO1999007843A1 Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith |
02/18/1999 | WO1999007837A1 Isolation and identification of novel polymerases |
02/18/1999 | WO1999007832A1 Kcnq potassium channels and methods of modulating same |
02/18/1999 | WO1999007823A1 Method and apparatus for separating particulate matter from a liquid specimen |
02/18/1999 | WO1999007750A1 Perfluorinated resins as a support for solid phase reactions |
02/18/1999 | WO1999007737A2 Lsr receptor, cloning and uses |
02/18/1999 | WO1999007736A2 Lipoprotein-regulating medicaments |
02/18/1999 | WO1999007728A2 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances |
02/18/1999 | WO1999007726A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
02/18/1999 | WO1999007471A1 System for providing biological materials |
02/18/1999 | WO1999007353A1 USE OF α1A-ADRENERGIC RECEPTOR ANTAGONISTS IN GLAUCOMA THERAPY |
02/18/1999 | WO1999007325A1 Liver function test |
02/18/1999 | WO1998053311A3 Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system |
02/18/1999 | WO1998049290A3 Syndecan interacting proteins and the use thereof |
02/18/1999 | WO1998042833A3 Kv potassium channel polypeptides and polynucleotides |